Release Date: 01/03/17 15:50 Summary: Appointment of new Chief Operating Officer Price Sensitive: No Download Document 38.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%